Sr. Medical Scientific Liaison (Northern) Italy

The role

The Senior Medical Science Liaison serves as a field-based scientific expert for rare neurodevelopmental diseases in Italy. This person will build relationships with healthcare professionals, drive scientific exchange, and generate medical insights to support therapeutic innovations.

What you will do

• Serve as the primary field-based scientific expert and partner for healthcare professionals and KOLs across Italy
• Drive launch excellence and lifecycle management by engaging stakeholders and generating insights
• Build strategic relationships with national and regional experts in rare pediatric neurological diseases
• Lead scientific exchange on marketed products and pipeline assets
• Identify and drive medical collaborations including investigator-initiated studies, publications, and speaker programs
• Plan and execute scientific advisory boards, expert meetings, symposia, and educational programs
• Represent the company at national and international congresses
• Gather and communicate field insights on clinical practice and unmet needs to inform medical strategy
• Partner with patient advocacy organizations to advance disease awareness and education
• Provide compliant responses to unsolicited medical information requests

Required qualifications

• An advanced scientific or medical degree or a related field
• 5 years of relevant industry experience
• 2+ years field-based (Sr) MSL roles in CNS/neuroscience or rare disease
• Ability to present complex scientific data clearly and effectively
• Highly organized, self-motivated, and able to work independently
• Collaborative, adaptable, and entrepreneurial
• Readiness to travel up to 70%

Nice to have

• The ideal candidate will have 5 years of relevant industry experience, including 2+ years field-based (Sr) MSL roles in CNS/neuroscience or rare disease

About the company

Acadia is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. Their portfolio includes treatments for Parkinson’s disease psychosis and Rett syndrome.